$SHMP
NaturalShrimp Inc Stock $shmp

$shmp Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222023485 Filed on August 18, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$51.73K	$36.34K	$17.13K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit	$51.73K	$36.34K
YoY Change
Gross Profit Margin	100.0%	100.0%
Selling, General & Admin	$1.938M	$1.858M	$45.89M
YoY Change	-11.22%	-1.37%	2939.83%
% of Gross Profit	3746.78%	5112.75%
Research & Development	$4.000K	$172.6K	$190.7K
YoY Change	-97.97%
% of Gross Profit	7.73%	475.13%
Depreciation & Amortization	$408.0K	$525.0K	$1.088M
YoY Change	0.92%	47.89%	252.61%
% of Gross Profit	788.79%	1444.85%
Operating Expenses	$2.718M	$2.923M	$46.92M
YoY Change	-2.38%	30.61%	2480.78%
Operating Profit	-$2.666M	-$2.887M
YoY Change	-4.24%	28.99%
Interest Expense	-$21.00M	$686.6K	-$931.2K
YoY Change	-32080.26%	742.12%	941.34%
% of Operating Profit
Other Income/Expense, Net	-$21.86M	$686.6K	$0.00
YoY Change	33194.73%	-311.5%
Pretax Income	-$24.53M	-$2.200M	-$47.52M
YoY Change	760.75%	-14.15%	2391.16%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$24.53M	-$2.200M	-$47.52M
YoY Change	760.75%	-14.15%	2392.56%
Net Earnings / Revenue	-47420.68%	-6055.09%	-277401.23%
Basic Earnings Per Share	-$0.03	$0.00
Diluted Earnings Per Share	-$33.53K	-$3.304K	-$72.89K
COMMON SHARES
Basic Shares Outstanding	746.0M shares	666.0M shares	642.2M shares
Diluted Shares Outstanding	731.6M shares	666.0M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$561.4K	$664.4K	$1.734M
YoY Change	-29.87%	-88.88%	1012.99%
Cash & Equivalents	$561.4K	$664.4K	$1.734M
Short-Term Investments
Other Short-Term Assets	$4.691M	$1.993M	$3.012M
YoY Change	1534.18%	244.36%	359.54%
Inventory	$109.2K	$104.5K	$69.17K
Prepaid Expenses	$791.2K	$1.993M	$1.512M
Receivables	$72.12K	$38.52K	$14.39K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.434M	$2.801M	$4.829M
YoY Change	399.64%	-57.25%	495.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.764M	$15.80M	$14.80M
YoY Change	-85.62%	28.05%	20.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.58M	$16.84M	$18.27M
YoY Change	-21.52%	75.56%	742.29%
Total Long-Term Assets	$31.57M	$32.65M	$33.07M
YoY Change	-5.47%	48.83%	129.56%
TOTAL ASSETS
Total Short-Term Assets	$5.434M	$2.801M	$4.829M
Total Long-Term Assets	$31.57M	$32.65M	$33.07M
Total Assets	$37.01M	$35.45M	$37.90M
YoY Change	7.31%	24.43%	149.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.176M	$3.252M	$2.803M
YoY Change	-16.89%	395.63%	190.96%
Accrued Expenses	$258.8K	$218.6K	$207.4K
YoY Change	-52.43%	-61.56%	-65.57%
Deferred Revenue
YoY Change
Short-Term Debt	$765.2K	$515.5K	$515.5K
YoY Change	48.46%	-0.15%	-70.11%
Long-Term Debt Due	$5.057M	$96.00K	$96.00K
YoY Change	4654.08%	-8.34%	-86.12%
Total Short-Term Liabilities	$43.77M	$19.68M	$21.85M
YoY Change	604.99%	834.1%	393.64%
LONG-TERM LIABILITIES
Long-Term Debt	$6.781M	$4.765M	$2.749M
YoY Change	26.32%	-11.69%	-49.3%
Other Long-Term Liabilities	$250.1K	$268.3K	$286.3K
YoY Change	-22.15%		3.94%
Total Long-Term Liabilities	$7.031M	$5.033M	$3.035M
YoY Change	23.58%	-6.72%	-46.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.77M	$19.68M	$21.85M
Total Long-Term Liabilities	$7.031M	$5.033M	$3.035M
Total Liabilities	$50.80M	$24.71M	$24.88M
YoY Change	326.97%	229.37%	145.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$177.9M	-$152.8M	-$150.0M
YoY Change	163.95%	-343.03%	179.48%
Common Stock	$75.17K	$74.10K	$67.50K
YoY Change	23.87%	22.95%	20.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$59.18M	-$34.89M	-$33.13M
YoY Change
Total Liabilities & Shareholders Equity	$37.01M	$35.45M	$37.90M
YoY Change	7.31%	24.43%	149.06%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$24.53M	-$2.200M	-$47.52M
YoY Change	760.75%	-14.15%	2392.56%
Depreciation, Depletion And Amortization	$408.0K	$525.0K	$1.088M
YoY Change	0.92%	47.89%	252.61%
Cash From Operating Activities	-$1.576M	-$2.055M	-$374.2K
YoY Change	-21.69%	-4.03%	-72.56%
INVESTING ACTIVITIES
Capital Expenditures	$282.2K	-$491.1K	-$533.0K
YoY Change	-136.06%	-219.41%	29.71%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$282.2K	-$491.1K	-$533.0K
YoY Change	-109.01%	-88.2%	29.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.191M	$1.476M	-24.00K
YoY Change	-4533.25%	-87.82%	-101.48%
NET CHANGE
Cash From Operating Activities	-1.576M	-$2.055M	-374.2K
Cash From Investing Activities	282.2K	-$491.1K	-533.0K
Cash From Financing Activities	1.191M	$1.476M	-24.00K
Net Change In Cash	-103.0K	-$1.070M	-931.2K
YoY Change	-98.01%	-118.39%	496.71%
FREE CASH FLOW
Cash From Operating Activities	-$1.576M	-$2.055M	-$374.2K
Capital Expenditures	$282.2K	-$491.1K	-$533.0K
Free Cash Flow	-$1.858M	-$1.563M	$158.7K
YoY Change	51.07%	-38.74%	-116.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Inventory Net InventoryNet	69170	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1993296	usd
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1511546	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	2800775	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	4829141	usd
CY2022Q2	SHMP	Cash Paid For Patent Acquisition CashPaidForPatentAcquisition		usd
CY2022Q2	SHMP	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci		usd
CY2022Q2	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess		usd
CY2022Q2	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2022Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022Q2	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022Q2	SHMP	Redemption Of Series D Ps RedemptionOfSeriesDPs		usd
CY2022Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021Q2	SHMP	Construction In Process Transferred To Fixed Assets ConstructionInProcessTransferredToFixedAssets		usd
CY2022Q2	SHMP	Shares Issued Upon Conversion Of Convertible Debentures SharesIssuedUponConversionOfConvertibleDebentures		usd
CY2021Q2	SHMP	Shares Issued Upon Conversion Of Preferred Stock SharesIssuedUponConversionOfPreferredStock		usd
CY2022Q2	SHMP	Cancellation Of Right Of Use Asset And Lease Liability CancellationOfRightOfUseAssetAndLeaseLiability		usd
CY2022Q2	SHMP	Shares Issued As Consideration For Patent Acquisition SharesIssuedAsConsiderationForPatentAcquisition		usd
CY2022Q2	SHMP	Shares Issued As Consideration For Acquisition Of Remaining Nci SharesIssuedAsConsiderationForAcquisitionOfRemainingNci		usd
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15804603	usd
CY2022Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings		usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14798103	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings		usd
CY2022Q2	SHMP	Additions To Derivative Liabilities AdditionsToDerivativeLiabilities		usd
CY2022Q2	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	46484	usd
CY2022Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1087101	usd
CY2022Q2	SHMP	Warrant Liability Reclass To Equity Upon Exercise WarrantLiabilityReclassToEquityUponExercise		usd
CY2022	SHMP	Warrant Liability Reclass To Equity Upon Exercise WarrantLiabilityReclassToEquityUponExercise		usd
CY2022Q2	SHMP	Patents Patents	6561000	usd
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q2	us-gaap	Accretion Expense AccretionExpense		usd
CY2022Q2	SHMP	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares		usd
CY2022Q1	SHMP	Patents Patents	6658500	usd
CY2022Q2	SHMP	License Agreement LicenseAgreement	9952376	usd
CY2021Q2	us-gaap	Dividends Dividends		usd
CY2022Q2	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2022Q1	SHMP	License Agreement LicenseAgreement	10222376	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature		usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2021Q2	SHMP	Conversion Of Series B Ps To Common Stock Amount ConversionOfSeriesBPsToCommonStockAmount		usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization		usd
CY2021Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001465470
CY2022Q2	dei	Amendment Flag AmendmentFlag	false
CY2022Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2022Q2	us-gaap	Escrow Deposit EscrowDeposit		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2021Q2	us-gaap	Revenues Revenues		usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2021Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2021Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2022Q1	us-gaap	Cash Cash	1734040	usd
CY2021Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2021Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2021Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022Q2	dei	Document Type DocumentType	10-Q
CY2022Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38517	usd
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2022Q2	SHMP	Additions To Warrant Liability AdditionsToWarrantLiability		usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14385	usd
CY2022Q1	us-gaap	Escrow Deposit EscrowDeposit	1500000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	104538	usd
CY2022Q2	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q2	dei	Entity File Number EntityFileNumber	000-54030
CY2022Q2	dei	Entity Registrant Name EntityRegistrantName	NATURALSHRIMP INCORPORATED
CY2022Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-3262176
CY2022Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	5501 LBJ Freeway
CY2022Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Suite 450 Dallas
CY2022Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
CY2022Q2	dei	City Area Code CityAreaCode	(888)
CY2022Q2	dei	Local Phone Number LocalPhoneNumber	791-9474
CY2022Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	745983222	shares
CY2022Q2	us-gaap	Cash Cash	664424	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	263517	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	282753	usd
CY2022Q2	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2022Q1	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16844010	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18271363	usd
CY2022Q2	us-gaap	Assets Assets	35449388	usd
CY2022Q1	us-gaap	Assets Assets	37898607	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3252080	usd
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	117032233	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2802787	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	989247	usd
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	500450	usd
CY2022Q2	SHMP	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	211795	usd
CY2022Q1	SHMP	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	203520	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	218558	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	207418	usd
CY2022Q2	SHMP	Accrued Expenses Related Parties AccruedExpensesRelatedParties	200000	usd
CY2022Q1	SHMP	Accrued Expenses Related Parties AccruedExpensesRelatedParties	200000	usd
CY2022Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	20044	usd
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	20044	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	96000	usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	96000	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	495412	usd
CY2022Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	495412	usd
CY2022Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	398857	usd
CY2022Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	296630	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	11787000	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	13101000	usd
CY2022Q2	SHMP	Warrant Liability WarrantLiability	2008000	usd
CY2022Q1	SHMP	Warrant Liability WarrantLiability	3923000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	19676993	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21846261	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	11900000	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	11900000	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	4669079	usd
CY2022Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	2629079	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	95604	usd
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	119604	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	268330	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	286253	usd
CY2022Q2	us-gaap	Liabilities Liabilities	24710006	usd
CY2022Q1	us-gaap	Liabilities Liabilities	24881197	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	740710500	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	740585500	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	674831624	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	674644124	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	74097	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	67500	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96701607	usd
CY2022Q2	SHMP	Stock Payable StockPayable	815052	usd
CY2022Q1	SHMP	Stock Payable StockPayable	20132650	usd
CY2022Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	56250	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152758426	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150036023	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-34892794	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-33133766	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35449388	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37898607	usd
CY2022Q2	us-gaap	Revenues Revenues	36336	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1326032	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1644262	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	172643	usd
CY2022Q2	us-gaap	Facility Costs FacilityCosts	531736	usd
CY2021Q2	us-gaap	Facility Costs FacilityCosts	239325	usd
CY2022Q2	us-gaap	Depreciation Depreciation	525229	usd
CY2021Q2	us-gaap	Depreciation Depreciation	354503	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	367500	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2923140	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2238090	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2886804	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2238090	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	502372	usd
CY2021Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	81536	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2040000	usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	236364	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	109953	usd
CY2022Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1314000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1915000	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	103200	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	686628	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-324653	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2200176	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2562743	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-2200176	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2562743	usd
CY2022Q2	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-141500	usd
CY2021Q2	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-817376	usd
CY2022Q2	us-gaap	Accretion Expense AccretionExpense	278500	usd
CY2021Q2	SHMP	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares	-5792947	usd
CY2022Q2	us-gaap	Dividends Dividends	102227	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2722403	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9173066	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	665999390	shares
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-33133766	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	481750	usd
CY2021Q2	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-76500	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	450606	usd
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	501477593	shares
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-304997	usd
CY2022Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	11140	usd
CY2021Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-33836	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	840000	usd
CY2022Q2	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-42500	usd
CY2022Q2	SHMP	Accretion Of Series E Preferred Shares AccretionOfSeriesEPreferredShares	-278500	usd
CY2022Q2	SHMP	Dividends Preferred Stock And Preference Stock DividendsPreferredStockAndPreferenceStock	-102227	usd
CY2022Q2	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	24375	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-2200176	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-34892794	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3070969	usd
CY2021Q2	SHMP	Issuance Of Common Share Upon Conversion Amount IssuanceOfCommonShareUponConversionAmount	421486	usd
CY2021Q2	SHMP	Exchange Of Series D Ps To Series E Ps ExchangeOfSeriesDPsToSeriesEPs	-3258189	usd
CY2021Q2	SHMP	Sale Of Common Shares And Warrants For Cash Less Offering Costs And Commitment Shares Amount SaleOfCommonSharesAndWarrantsForCashLessOfferingCostsAndCommitmentSharesAmount	17277123	usd
CY2021Q2	SHMP	Exercise Of Warrants Related To The Sale Of Common Shares Amount ExerciseOfWarrantsRelatedToTheSaleOfCommonSharesAmount	11000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3269505	usd
CY2021Q2	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-817376	usd
CY2021Q2	SHMP	Redemption Of Series D Preferred Shares RedemptionOfSeriesDPreferredShares	-2534758	usd
CY2021Q2	SHMP	Common Shares To Be Issued For Acquisition Of Noncontrolling Interest Subsidiarys Remaining Equity CommonSharesToBeIssuedForAcquisitionOfNoncontrollingInterestSubsidiarysRemainingEquity	-1000000	usd
CY2021Q2	SHMP	Common Shares To Be Issued For Patent Acquisition CommonSharesToBeIssuedForPatentAcquisition	5000000	usd
CY2021Q2	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	73651	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2562743	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18950668	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2200176	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2562743	usd
CY2022Q2	us-gaap	Depreciation Depreciation	525229	usd
CY2021Q2	us-gaap	Depreciation Depreciation	354503	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	367500	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2040000	usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	236364	usd
CY2022Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1314000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1915000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	109953	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	103200	usd
CY2022Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	24375	usd
CY2021Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	73651	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24132	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	35368	usd
CY2022Q2	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	488797	usd
CY2021Q2	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	13018	usd
CY2022Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	8275	usd
CY2021Q2	SHMP	Redemption Of Series D Ps RedemptionOfSeriesDPs	-3513504	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2054504	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2140787	usd
CY2022Q2	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	491112	usd
CY2021Q2	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	411293	usd
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17277123	usd
CY2021Q2	SHMP	Cash Paid For Patent Acquisition CashPaidForPatentAcquisition	2000000	usd
CY2022Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1500000	usd
CY2021Q2	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	421486	usd
CY2021Q2	SHMP	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci	1000000	usd
CY2021Q2	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	749651	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-491112	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4160944	usd
CY2021Q2	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	2042	usd
CY2022Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	24000	usd
CY2021Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	24000	usd
CY2021Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	655750	usd
CY2021Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	552788	usd
CY2021Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1476000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12118553	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1069616	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5816822	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1734040	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155795	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	664424	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5972617	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	5300	usd
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet	81536	usd
CY2022Q2	SHMP	Construction In Process Transferred To Fixed Assets ConstructionInProcessTransferredToFixedAssets	1040617	usd
CY2021Q2	SHMP	Shares Issued Upon Conversion Of Convertible Debentures SharesIssuedUponConversionOfConvertibleDebentures	421486	usd
CY2022Q2	SHMP	Shares Issued Upon Conversion Of Preferred Stock SharesIssuedUponConversionOfPreferredStock	840000	usd
CY2021Q2	SHMP	Cancellation Of Right Of Use Asset And Lease Liability CancellationOfRightOfUseAssetAndLeaseLiability	275400	usd
CY2021Q2	SHMP	Shares Issued As Consideration For Patent Acquisition SharesIssuedAsConsiderationForPatentAcquisition	5000000	usd
CY2021Q2	SHMP	Shares Issued As Consideration For Acquisition Of Remaining Nci SharesIssuedAsConsiderationForAcquisitionOfRemainingNci	2000000	usd
CY2022Q2	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_zKUwOswbh0Hg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 – <span id="xdx_827_zFijcic7vRQ8">NATURE OF THE ORGANIZATION AND BUSINESS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Nature of the Business</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a biotechnology company and has developed a proprietary technology that allows it to grow Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities. The Company’s system uses technology which allows it to produce a naturally-grown shrimp “crop” weekly and accomplishes this without the use of antibiotics or toxic chemicals. The Company has developed several proprietary technology assets, including a knowledge base that allows it to produce commercial quantities of shrimp in a closed system with a computer monitoring system that automates, monitors and maintains proper levels of oxygen, salinity and temperature for optimal shrimp production. The Company’s production facilities are located in La Coste, Texas and Webster City, Iowa.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On December 15, 2020, the Company entered into an Asset Purchase Agreement (“APA”) between VeroBlue Farms USA, Inc., a Nevada corporation (“VBF”), VBF Transport, Inc., a Delaware corporation (“Transport”), and Iowa’s First, Inc., an Iowa corporation (“Iowa’s First”) (each a “Seller” and collectively, “Sellers”). Transport and Iowa’s First were wholly-owned subsidiaries of VBF. The agreement called for the Company to purchase all of the tangible assets of VBF, the motor vehicles of Transport and the real property (together with all plants, buildings, structures, fixtures, fittings, systems and other improvements located on such real property) of Iowa’s First. The facility was originally designed as an aquaculture facility, with the company having production issues. The Company began a modification process to convert the plant to produce shrimp, which will allow them to scale faster without having to build new facilities. The three Iowa facilities contain the tanks and infrastructure that will be used to support the production of shrimp with the incorporation of the Company’s patented EC platform technology. On May 19, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with F&T Water Solutions, LLC (“F&T”), for F&T’s owned shares of Natural Aquatic Systems, Inc. (“NAS”). Prior to entering into the SPA, the Company owned fifty-one percent (<span id="xdx_907_eus-gaap--VariableInterestEntityOwnershipPercentage_pid_dp_c20220401__20220630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zVohgZnj2Ux5" title="Variable interest entity, ownership percentage">51</span>%) and F&T owned forty-nine percent (<span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_c20220401__20220630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--NaturalAquaticSystemsIncMember_zRQumNWk0WQ4" title="Issued and outstanding shares of common, percentage">49</span>%) of the issued and outstanding shares of common stock of NAS. After the SPA, NAS is a <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20220630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NaturalAquaticSystemsIncMember_z5r1GNEBFpha" title="Ownership percentage">100</span>% owned subsidiary of the Company<span style="font-size: 8pt"/>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has three wholly-owned subsidiaries including NaturalShrimp USA Corporation, NaturalShrimp Global, Inc. and NAS.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the three months ended June 30, 2022, the Company had a net loss available for common stockholders of approximately $<span id="xdx_900_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iN_pn3d_di_c20220401__20220630_zTqt5qfK6gD9" title="Net loss available for common stockholders">2,722,000</span>. At June 30, 2022, the Company had an accumulated deficit of approximately $<span id="xdx_90A_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3p0_di_c20220630_zOaWvSLKc2Be" title="Accumulated deficit">152,758,000</span> and a working capital deficit of approximately $<span id="xdx_90C_ecustom--WorkingCapitalDeficit_iNI_di_c20220630_zuEaRoeucASf" title="Working capital deficit">16,876,000</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of this filing. The Company’s ability to continue as a going concern is dependent on its ability to raise the required additional capital or debt financing to meet short and long-term operating requirements. During the three months ended June 30, 2022, the Company received the $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20220401__20220630_pp0p0" title="Proceeds from convertible debentures, receipt from escrow">1,500,000</span> remaining escrow amount related to the proceeds from the issuance of a convertible debenture in December 2021. Subsequent to the period end, the Company received $<span id="xdx_901_eus-gaap--ProceedsFromRelatedPartyDebt_c20220701__20220731__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLWFCKRIYGo7">250,000</span> in a loan agreement with related parties. Management believes that private placements of equity capital will be needed to fund the Company’s long-term operating requirements. The Company may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a requirement for additional cash. If the Company raises additional funds through the issuance of equity, the percentage ownership of its current shareholders could be reduced, and such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict our operations. The Company continues to pursue external financing alternatives to improve its working capital position. If the Company is unable to obtain the necessary capital, the Company may be unable to develop its facilities and enter in production.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2722000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152758000	usd
CY2022Q2	SHMP	Working Capital Deficit WorkingCapitalDeficit	-16876000	usd
CY2022Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1500000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2420815	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	13101000	usd
CY2022	SHMP	Additions To Derivative Liabilities AdditionsToDerivativeLiabilities	12985000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1909612	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1314000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15804603	usd
CY2022Q2	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zrRcTH9hskMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Use of Estimates</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18506429	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10000000	shares
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	116000	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	11787000	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	13101000	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3923000	usd
CY2022	SHMP	Additions To Warrant Liability AdditionsToWarrantLiability	5910000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1915000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1987000	usd
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2008000	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3923000	usd
CY2022Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_z28izXIXnmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentration of Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company maintains cash balances at two financial institutions. Accounts at this institution are insured by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20220630_zo5wYT8zDLF2" title="Cash, FDIC insured amount">250,000</span>. <span style="background-color: white">As of </span>June 30, 2022 <span style="background-color: white">and March 31, 2022, the Company’s cash balance exceeded FDIC coverage. </span>The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14798103	usd
CY2022Q2	us-gaap	Depreciation Depreciation	525000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	355000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022Q2	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	99000	usd
CY2022Q2	us-gaap	Land Land	324293	usd
CY2022Q1	us-gaap	Land Land	324293	usd
CY2022Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5611723	usd
CY2022Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5611723	usd
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	12026071	usd
CY2022Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10524343	usd
CY2022Q2	SHMP	Automobiles Gross AutomobilesGross	263331	usd
CY2022Q1	SHMP	Automobiles Gross AutomobilesGross	247356	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18225418	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16707715	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18506429	shares
CY2022Q2	SHMP	Fair Value Of Warrants FairValueOfWarrants	2008000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	300	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	11787000	usd
CY2022Q2	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	1314000	usd
CY2022Q2	SHMP	Decrease In Fair Value Of Warrant DecreaseInFairValueOfWarrant	1915000	usd
CY2022Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	119000	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	50000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	50000	usd
CY2016Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02	pure
CY2022Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	154000	usd
CY2022Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	146000	usd
CY2022Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	290000	usd
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2021Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1727	usd
CY2022Q2	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
CY2021Q2	us-gaap	Deposits Deposits	52362	usd
CY2021Q2	us-gaap	Security Deposit SecurityDeposit	17454	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	316000	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure

Files In Submission

Name	View Source	Status
0001493152-22-023485-index-headers.html	Edgar Link	pending
0001493152-22-023485-index.html	Edgar Link	pending
0001493152-22-023485.txt	Edgar Link	pending
0001493152-22-023485-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shmp-20220630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
shmp-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
shmp-20220630_lab.xml	Edgar Link	unprocessable
shmp-20220630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
shmp-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHMP
NaturalShrimp Inc Stock $shmp

2022 Q3 Form 10-Q Financial Statement

#000149315222023485 Filed on August 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP NaturalShrimp Inc Stock $shmp

2022 Q3 Form 10-Q Financial Statement

#000149315222023485 Filed on August 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP
NaturalShrimp Inc Stock $shmp